These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 499308)

  • 1. Pharmacokinetics of cefoxitin in patients with normal or impaired renal function.
    Garcia MJ; Dominguez-Gil A; Tabernero JM; Sanchez Tomero JA
    Eur J Clin Pharmacol; 1979 Sep; 16(2):119-24. PubMed ID: 499308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of cefoxitin administered intramuscularly to rabbits with experimentally-induced renal impairment.
    Garcia MJ; Dominguez-Gil AA; Cepeda M; Dominguez-Gil A
    Biopharm Drug Dispos; 1981; 2(3):205-13. PubMed ID: 7295878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of Amikacin (BB-K8) in patients with normal or impaired renal function.
    Lanao JM; Domínguez-Gil A; Tabernero JM; De Castro S
    Int J Clin Pharmacol Biopharm; 1979 Apr; 17(4):171-5. PubMed ID: 447438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disposition of cefoxitin in the elderly.
    Garcia MJ; Garcia A; Nieto MJ; Dominguez-Gil A; Alonso G; Mellado L
    Int J Clin Pharmacol Ther Toxicol; 1980 Nov; 18(11):503-9. PubMed ID: 7203727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of cefoxitin in patients undergoing hemodialysis.
    Garcia MJ; Dominguez-Gil A; Tabernero JM; Bondia Román A
    Int J Clin Pharmacol Biopharm; 1979 Aug; 17(8):366-70. PubMed ID: 489205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cefoxitin pharmacokinetics: relation to three different renal clearance studies in patients with various degrees of renal insufficiency.
    Kampf D; Schurig R; Korsukewitz I; Brückner O
    Antimicrob Agents Chemother; 1981 Dec; 20(6):741-6. PubMed ID: 7325641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pleural fluid levels of cefoxitin in patients with renal impairment.
    Barrueco M; Otero MJ; Garcia MJ; Lanao JM; Dominguez-Gil A
    Int J Clin Pharmacol Ther Toxicol; 1986 Sep; 24(9):485-9. PubMed ID: 3781682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of experimentally induced renal impairment on the pharmacokinetics of cefadroxil in rabbits.
    Mariño EL; Dominguez-Gil AA; Cepeda M; Otero MJ; Dominguez-Gil A
    Arzneimittelforschung; 1981; 31(3):478-81. PubMed ID: 7194673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of cefamandole in rabbits with experimentally induced renal impairment.
    Campillo JA; Dominguez-Gil AA; Cepeda M; Dominguez-Gil A
    J Antibiot (Tokyo); 1980 Mar; 33(3):322-7. PubMed ID: 7380743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of cephacetrile in patients undergoing haemodialysis.
    Dominguez-Gil A; Lanao JM; Tabernero JM; Rodriguez Commes JL; de Castro S
    Eur J Clin Pharmacol; 1979 Aug; 16(1):49-52. PubMed ID: 499300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of amoxicillin in subjects with normal and impaired renal function.
    Arancibia A; Drouguett MT; Fuentes G; González G; González C; Thambo S; Palombo G
    Int J Clin Pharmacol Ther Toxicol; 1982 Oct; 20(10):447-53. PubMed ID: 7141752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of amikacin (BB-K8) in patients undergoing hemodialysis.
    Lanao JM; Dominguez-Gil A; Tabernero JM; Sanchez Tomero JA
    Int J Clin Pharmacol Biopharm; 1979 Aug; 17(8):357-60. PubMed ID: 489203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of cefamandole in patients undergoing hemodialysis.
    Campillo JA; Lanao JM; Dominguez-Gil A; Tabernero JM; Rubio F
    Int J Clin Pharmacol Biopharm; 1979 Sep; 17(9):416-20. PubMed ID: 500264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of acute renal impairment in the penetration of cefoxitin into interstitial tissue fluid in rabbits.
    Dominguez-Gil AA; Garcia MJ; Cepeda M; Lanao JM; Dominguez-Gil A
    Clin Ther; 1981; 3(6):413-24. PubMed ID: 7260987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of ciprofloxacin in healthy volunteers and patients with impaired kidney function.
    Webb DB; Roberts DE; Williams JD; Asscher AW
    J Antimicrob Chemother; 1986 Nov; 18 Suppl D():83-7. PubMed ID: 3804907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of cefoxitin administered by i.v. infusion to patients with a pleural effusion.
    Otero MJ; Garcia MJ; Barrueco M; Dominguez-Gil A; Gomez F; Portugal Alvarez J
    Eur J Clin Pharmacol; 1984; 26(3):389-92. PubMed ID: 6734700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significance of ratios of different volumes of distribution in pharmacokinetics.
    Wagner JG
    Biopharm Drug Dispos; 1983; 4(3):263-70. PubMed ID: 6626701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of cefoxitin in normal subjects and in patients with renal insufficiency.
    Humbert G; Fillastre JP; Leroy A; Godin M; Van Winzum C
    Rev Infect Dis; 1979; 1(1):118-26. PubMed ID: 318213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of cefoxitin in patients with pleural effusion on a multiple dosage regimen.
    Garcia MJ; Otero MJ; Barrueco M; Dominguez-Gil A
    Int J Clin Pharmacol Ther Toxicol; 1984 Jun; 22(6):300-3. PubMed ID: 6746153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disposition of cefoxitin in patients with pleural effusion.
    Barrueco M; Garcia MJ; Otero MJ; Dominguez-Gil A; de Letona JM
    Clin Ther; 1981; 3(6):425-35. PubMed ID: 7260988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.